Suppr超能文献

小儿青光眼的带瓣青光眼引流装置:回顾性长期结果

Valved Glaucoma Drainage Devices in Pediatric Glaucoma: Retrospective Long-term Outcomes.

作者信息

Chen Andrew, Yu Fei, Law Simon K, Giaconi JoAnn A, Coleman Anne L, Caprioli Joseph

机构信息

Stein Eye Institute, David Geffen School of Medicine, University of California, Los Angeles.

Stein Eye Institute, David Geffen School of Medicine, University of California, Los Angeles2Department of Biostatistics, Jonathan and Karin Fielding School of Public Health, University of California, Los Angeles.

出版信息

JAMA Ophthalmol. 2015 Sep;133(9):1030-5. doi: 10.1001/jamaophthalmol.2015.1856.

Abstract

IMPORTANCE

Relatively little data exist about the long-term outcomes of an initial glaucoma drainage device (GDD) and subsequent GDDs implanted in pediatric patients with glaucoma.

OBJECTIVE

To determine the long-term outcomes of the first and second GDDs and risk factors in pediatric glaucoma.

DESIGN, SETTING, AND PARTICIPANTS: Retrospective review of 119 eyes of 89 patients younger than 18 years with glaucoma who underwent valved GDD implantation from March 1999 to April 2012 at the Stein Eye Institute, University of California, Los Angeles.

EXPOSURE

Implantation of GDD, using silicone and polypropylene Ahmed glaucoma valve.

MAIN OUTCOMES AND MEASURES

Kaplan-Meier survival analysis and risk factors associated with GDD failure. Success was defined as a final intraocular pressure of 5 to 21 mm Hg as well as a 20% reduction from baseline intraocular pressure with or without medications.

RESULTS

The mean (SD) age at implantation of the first GDD was 6.8 (5.7) years. The mean (SD) follow-up time was 6.1 (3.3) years from surgery. The mean intraocular pressure was reduced by 13.0 mm Hg (95% CI, 8.8 to 17.3 mm Hg) at 5 years postoperatively. The mean number of glaucoma medications preoperatively vs postoperatively was not different starting at 5 years (reduction of 0.5; 95% CI, -0.1 to 1.0). The success rate at 5 years was 55.0% (95% CI, 46.0% to 65.9%). Risk factor analysis suggests that older age (risk ratio = 0.95; 95% CI, 0.90 to 0.99; P = .02), uveitic glaucoma (risk ratio = 0.34; 95% CI, 0.14 to 0.86; P = .02), and polypropylene GDDs (risk ratio = 0.39; 95% CI, 0.23 to 0.67; P = .001) were associated with higher success rates. Thirty-six eyes received a second GDD, with a mean (SD) of 2.2 (1.6) years between the 2 operations. The success rate 5 years after the second surgery was 52.8% (95% CI, 37.0% to 75.3%). Risk factors associated with failure of the first GDD were not found to affect the likelihood of failure for the second.

CONCLUSIONS AND RELEVANCE

Glaucoma drainage devices, such as the Ahmed glaucoma valve, have moderate long-term success rates in pediatric patients with glaucoma. In pediatric patients, the first GDD is successful in 46% to 70% of patients at 5 years with medications, and the second GDD is successful in 37% to 75% of patients at 5 years after the subsequent surgery.

摘要

重要性

关于青光眼引流装置(GDD)首次植入及后续植入儿科青光眼患者的长期预后数据相对较少。

目的

确定儿科青光眼患者首次和第二次GDD植入的长期预后及危险因素。

设计、设置和参与者:对1999年3月至2012年4月在加利福尼亚大学洛杉矶分校斯坦眼科研究所接受带瓣GDD植入术的89例18岁以下青光眼患者的119只眼睛进行回顾性研究。

暴露因素

使用硅胶和聚丙烯艾哈迈德青光眼阀植入GDD。

主要结局和测量指标

Kaplan-Meier生存分析以及与GDD失败相关的危险因素。成功定义为最终眼压为5至21 mmHg,以及眼压较基线眼压降低20%(无论是否使用药物)。

结果

首次植入GDD时的平均(标准差)年龄为6.8(5.7)岁。从手术开始的平均(标准差)随访时间为6.1(3.3)年。术后5年眼压平均降低13.0 mmHg(95%CI,8.8至17.3 mmHg)。从术后5年开始,术前与术后青光眼药物的平均使用数量没有差异(减少0.5;95%CI,-0.1至1.0)。5年时的成功率为55.0%(95%CI,46.0%至65.9%)。危险因素分析表明,年龄较大(风险比=0.95;95%CI,0.90至0.99;P=0.02)、葡萄膜炎性青光眼(风险比=0.34;95%CI,0.14至0.86;P=0.02)和聚丙烯GDD(风险比=0.39;95%CI,0.23至0.67;P=0.001)与较高的成功率相关。36只眼睛接受了第二次GDD植入,两次手术之间的平均(标准差)间隔时间为2.2(1.6)年。第二次手术后5年的成功率为52.8%(95%CI,37.0%至75.3%)。未发现与首次GDD失败相关的危险因素会影响第二次GDD失败的可能性。

结论和相关性

青光眼引流装置,如艾哈迈德青光眼阀,在儿科青光眼患者中具有中等的长期成功率。在儿科患者中,首次GDD植入在5年时使用药物的情况下,46%至70%的患者成功,第二次GDD植入在后续手术后5年时,37%至75%的患者成功。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验